8.2.1 Antiproliferative immunosuppressants
Azathioprine
Azathioprine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Azathioprine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Mycophenolate mofetil
Mycophenolate mofetil 250mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Mycophenolate mofetil 500mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Malignant disease and immunosuppression | Solid organ transplantation |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Respiratory system | Pulmonary fibrosis |
Mycophenolic acid
Mycophenolic acid 360mg gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |